Point of Care Molecular Diagnostics Market 2019 SWOT Analysis with Top Key Players: Agilent Technologies, Abbott, Roche, Hologic, QIAGEN, Myriad Genetics, Cepheid, Genomic Health, Mckesson Corporation, Accretive Health, Hcl Technologies, Hewlett-Packard

This report studies the Global Point of Care Molecular Diagnostics Market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the Global Point of Care Molecular Diagnostics market by companies, region, type and end-use industry.

Data Bridge Market Research recently introduced Global Point of Care Molecular Diagnostics Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2025. The market Study is segmented by key regions which is accelerating the marketization.

To request a FREE sample copy of this report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-point-of-care-molecular-diagnostics-market

Point of Care Molecular Diagnostics is diagnostic equipment which is used to determine the cause of infectious disease causing agents. These machines/equipments help determine the accurate cause of these diseases in a timely manner, which is of utmost importance when dealing with these kind of diseases and also to implement the correct course of action.

Key Developments in the Market:

• In October 2017, Abbott completed the acquisition of Alere, for USD 5.9 billion. Alere was a global leader in diagnostics market and the acquisition helps Abbott grow its market share.

• In July 2017, Agilent Technologies announced the acquisition of Population Genetics’ molecular and sample barcoding patent portfolios which help improve the accuracy of next generation sequencing (NGS). These help in the diagnostics of cancer.

Segmentation:

• By Product
1. Assays & Kits
2. Instruments/Analyzers
3. Services & Software
4. By Application
5. Respiratory Diseases
6. Sexually Transmitted Diseases
7. Hospital-acquired Infection
8. Oncology
9. Hepatitis
10. Others

• By Technology
1. Polymerase Chain Reaction
 Real Time Polymerase Chain Reaction
 DNA/RNA Purification
2. In-Situ Hybridization
3. Chips and Microarrays
4. Mass Spectrometry
5. Sequencing
6. Isothermal Amplification
7. Others

• By Geography
1. North America
2. South America
3. Europe
4. Asia-Pacific
5. Middle East & Africa

Make an Inquiry for purchasing this report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-point-of-care-molecular-diagnostics-market

The report also includes a description of key factors, which tends to significantly spur or breach the market growth. The report also enlightens on the future impact of the administration policies and regulations on the growth of the market. The calculated expected CAGR of the market on the basis of previous data about the market, and ongoing market trends along with future developments are also included in the report.

Top Competitors:

• Agilent Technologies Inc.,
• Abbott,
• F. Hoffmann-La Roche Ltd.,
• Illumina Inc.,
• Hologic Inc.,
• QIAGEN,

Few more others companies are Myriad Genetics, Cepheid, Genomic Health, GenePOC Inc., DxNA LLC., Binx Health Inc., Spartan Bioscience Inc., Biocartis, Beckman Coulter Inc., Johnson & Johnson Services Inc., Medtronic, Siemens Healthcare GmbH, Grifols S.A., Abaxis, Bayer AG, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher, OraSure Technologies Inc., BD, Sysmex Corporation, Quidel Corporation, and Meridian Bioscience Inc.

Target Audiences:

1. Physician Offices
2. Hospitals
3. Research Institutes
4. Others

Global Point of Care Molecular Diagnostics Market Market, projects a standardized and in-depth study on the ongoing state of Market, providing basic industry insights such as definitions, classifications, supply chain, applications and industry cost structure. The report precisely delivers productive information about development policies and plans as well as manufacturing processes and techniques.

Market Drivers:

• Increasing cases of infectious diseases causing the health professionals to determine the infections and its causes accurately in a timely manner, thereby increasing the demand for Point of Care Molecular Diagnostics Market.

• Increased demand for regulatory approved molecular tests driving the market

To Understand Complete Table Of Content, Tables And Figures @ https://databridgemarketresearch.com/toc/?dbmr=global-point-of-care-molecular-diagnostics-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.